MELBOURNE, Australia — In a major step toward protecting ancient indigenous medicine, India and Australia have signed a landmark agreement giving Australian patent examiners access to India’s Traditional Knowledge Digital Library (TKDL). The agreement was finalized on July 9, 2026, during the 3rd India–Australia Annual Summit in Melbourne. Conducted in the presence of Indian Prime Minister Narendra Modi and Australian Prime Minister Anthony Albanese, this pact aims to close loopholes that allow international corporations to claim exclusive patents on centuries-old natural remedies.
Under the new treaty, IP Australia—the nation’s patent-awarding agency—will integrate India’s vast digital repository of traditional medical formulations directly into its screening workflows. This integration allows examiners to quickly identify “prior art” (existing public knowledge) before granting patents. The move protects the cultural heritage of both nations, ensuring that ancient remedies remain open, accessible, and free from corporate monopolies.
The Digital Shield Against Biopiracy
For decades, the global intellectual property framework struggled to protect traditional knowledge. Western patent systems often granted exclusive commercial rights to companies that made minor tweaks to well-known natural remedies. A classic example occurred in the late 1990s when a U.S. patent was granted for the wound-healing properties of turmeric—a remedy Indian families have used for generations. That patent was eventually revoked after a long, costly legal battle led by India.
To prevent these errors, India established the TKDL in 2001 as a collaborative project between the Council of Scientific and Industrial Research (CSIR) and the Ministry of AYUSH. It operates as a digital archive that translates ancient texts into modern structural data.
ANCIENT SOURCE TEXTS CSIR-TKDL ARCHIVE PATENT EXAMINATION
[Sanskrit, Tamil, Persian] ======> [520,000+ Formulations] ======> [18 Global Patent Offices]
(Ayurveda, Unani, Siddha) (Searchable in 5 Languages) (Now including IP Australia)
The repository acts as a bridge between ancient heritage and modern intellectual property law. It standardizes and translates more than 520,000 formulations and practices across five traditional systems:
-
Ayurveda: The ancient Indian system of holistic medicine.
-
Unani: A traditional system of healing practiced widely in South Asia.
-
Siddha: One of India’s oldest therapeutic systems, originating in the south.
-
Sowa Rigpa: The traditional medical system of the Himalayan regions.
-
Yoga: Documented postures, breathing techniques, and preventative wellness practices.
To help international patent offices use the data, the CSIR has translated these complex formulations into five global languages: English, German, French, Japanese, and Spanish. Australia is the 18th international patent office to gain access to this secure library under a strict Non-Disclosure Agreement (NDA).
Why Prior Art Matters for Public Health
At its core, this agreement changes how new drugs and wellness products are screened. In patent law, an invention must be completely new and non-obvious to qualify for protection. However, because ancient medical formulas were recorded in languages like Sanskrit, Tamil, or Persian, international patent examiners routinely missed them.
“When a patent office lacks access to indigenous records, it operates in a vacuum,” says Dr. Elena Rostov, an independent intellectual property researcher specializing in global health policy. “A company can take a well-known remedy, like a specific herbal blend for joint pain, wrap it in clinical terminology, and secure a patent. This blocks others from selling that remedy and drives up costs for consumers. This agreement ensures that what is already public property stays in the public domain.”
The defensive strategy works well. To date, evidence supplied by the TKDL has led to more than 375 patent applications worldwide being revoked, rejected, amended, or abandoned. The process is overseen by a team of experts, including:
-
Mr. Andrew Wilkinson, Commissioner of Patents, IP Australia
-
Dr. N. Kalaiselvi, Director General of CSIR
-
Dr. Viswajanani
J. Sattigeri, Head of the CSIR-TKDL Unit
Shared Vulnerabilities and Indigenous Rights
The timing of the pact aligns with global efforts to protect indigenous knowledge. Australia is home to the world’s oldest continuous living culture. Its Aboriginal and Torres Strait Islander communities hold deep expertise in native flora, such as Kakadu plum and tea tree oil, which face similar commercial exploitation risks.
The agreement creates a shared framework for both nations to improve how they document and protect indigenous knowledge. Both countries are working to ensure that the communities who originally discovered these therapies retain control over them, preventing unauthorized exploitation.
Balancing Innovation and Heritage
While health advocates welcome the agreement, some industry analysts urge caution. They note that over-regulating natural compounds could slow down legitimate research.
“We need to distinguish between biopiracy and genuine innovation,” notes Marcus Vance, an intellectual property consultant for the pharmaceutical sector. “If an international lab isolates a specific molecule from a traditional plant, runs it through multi-phase clinical trials, and engineers a targeted, life-saving medication, they deserve patent protection. The danger arises if defensive databases like the TKDL are interpreted too broadly, discouraging companies from investing the millions of dollars required to bring safe, standardized plant-derived drugs to the global market.”
Furthermore, while the TKDL is highly effective for documented practices, it does not cover undocumented oral traditions passed down through generations of indigenous healers. This leaves a significant gap in protection that policymakers still need to address.
What This Means for Consumers
For health-conscious consumers and healthcare providers, the practical benefits of this treaty are clear:
-
Protects Affordable Choices: By blocking wrongful patents, the agreement prevents corporations from monopolizing natural ingredients. This keeps traditional supplements and herbal remedies accessible and affordable.
-
Preserves Natural Options: It ensures that traditional remedies remain legally available for public use, rather than being restricted by corporate ownership.
-
Encourages Fair Partnerships: Companies wanting to use traditional knowledge are encouraged to form ethical partnerships with indigenous communities, ensuring fair compensation and respect for cultural history.
As natural wellness products gain popularity worldwide, agreements like this ensure that the future of medicine respects its ancient roots.
Reference Section
Government & Institutional Documents
-
Press Information Bureau (PIB) Delhi. (2026, July 10). India and Australia Sign Agreement on Access to Council of Scientific and Industrial Research’s Traditional Knowledge Digital Library (CSIR-TKDL) to Strengthen Protection of Traditional Knowledge. Ministry of Science & Technology, Government of India.
- Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.